These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 12946232)

  • 1. Current challenges in cystic fibrosis screening.
    Lyon E; Miller C
    Arch Pathol Lab Med; 2003 Sep; 127(9):1133-9. PubMed ID: 12946232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.
    Comeau AM; Parad RB; Dorkin HL; Dovey M; Gerstle R; Haver K; Lapey A; O'Sullivan BP; Waltz DA; Zwerdling RG; Eaton RB
    Pediatrics; 2004 Jun; 113(6):1573-81. PubMed ID: 15173476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening for cystic fibrosis in US genetic testing laboratories: a survey of laboratory directors.
    Kaufman DJ; Katsanis SH; Javitt GH; Murphy JA; Scott JA; Hudson KL
    Clin Genet; 2008 Oct; 74(4):367-73. PubMed ID: 18700896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dangers of including nonclassical cystic fibrosis variants in population-based screening panels: p.L997F, further genotype/phenotype correlation data.
    Strom CM; Redman JB; Peng M
    Genet Med; 2011 Dec; 13(12):1042-4. PubMed ID: 21804385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric and Adult Recommendations Vary for Sibling Testing in Cystic Fibrosis.
    Brown KL; Flume PA
    J Genet Couns; 2018 Sep; 27(5):1049-1054. PubMed ID: 29429040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cystic fibrosis transmembrane conductance regulator (CFTR) gene: mutations and clinical phenotypes].
    Schwartz M
    Ugeskr Laeger; 2003 Feb; 165(9):912-6. PubMed ID: 12661515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in cystic fibrosis newborn screening program outcomes with genetic counseling via telemedicine.
    Stalker HJ; Jonasson AR; Hopfer SM; Collins MS
    Pediatr Pulmonol; 2023 Dec; 58(12):3478-3486. PubMed ID: 37712603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis: molecular diagnosis, population screening, and public policy.
    Grody WW
    Arch Pathol Lab Med; 1999 Nov; 123(11):1041-6. PubMed ID: 10539904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosing cystic fibrosis in newborn screening in Poland - 15 years of experience.
    Sands D; Zybert K; Mierzejewska E; OĊ‚tarzewski M
    Dev Period Med; 2015; 19(1):16-24. PubMed ID: 26003066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic diagnosis in practice: From cystic fibrosis to CFTR-related disorders.
    Pagin A; Sermet-Gaudelus I; Burgel PR
    Arch Pediatr; 2020 Feb; 27 Suppl 1():eS25-eS29. PubMed ID: 32172933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular testing for cystic fibrosis carrier status practice guidelines: recommendations of the National Society of Genetic Counselors.
    Langfelder-Schwind E; Karczeski B; Strecker MN; Redman J; Sugarman EA; Zaleski C; Brown T; Keiles S; Powers A; Ghate S; Darrah R
    J Genet Couns; 2014 Feb; 23(1):5-15. PubMed ID: 24014130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carrier screening for cystic fibrosis: a perinatal perspective.
    Demsey SA
    J Perinat Neonatal Nurs; 1999 Sep; 13(2):14-26. PubMed ID: 10818851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on cystic fibrosis screening.
    Goetzinger KR; Cahill AG
    Clin Lab Med; 2010 Sep; 30(3):533-43. PubMed ID: 20638569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process.
    Ciske DJ; Haavisto A; Laxova A; Rock LZ; Farrell PM
    Pediatrics; 2001 Apr; 107(4):699-705. PubMed ID: 11335747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis.
    Bishop MD; Freedman SD; Zielenski J; Ahmed N; Dupuis A; Martin S; Ellis L; Shea J; Hopper I; Corey M; Kortan P; Haber G; Ross C; Tzountzouris J; Steele L; Ray PN; Tsui LC; Durie PR
    Hum Genet; 2005 Dec; 118(3-4):372-81. PubMed ID: 16193325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The c.1364C>A (p.A455E) Mutation in the CFTR Pseudogene Results in an Incorrectly Assigned Carrier Status by a Commonly Used Screening Platform.
    Deeb KK; Metcalf JD; Sesock KM; Shen J; Wensel CA; Rippel LI; Smith M; Chapman MS; Zhang S
    J Mol Diagn; 2015 Jul; 17(4):360-5. PubMed ID: 25956447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cystic fibrosis testing 8 years on: lessons learned from carrier screening and sequencing analysis.
    Strom CM; Crossley B; Buller-Buerkle A; Jarvis M; Quan F; Peng M; Muralidharan K; Pratt V; Redman JB; Sun W
    Genet Med; 2011 Feb; 13(2):166-72. PubMed ID: 21068670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genotyping microarray for the detection of more than 200 CFTR mutations in ethnically diverse populations.
    Schrijver I; Oitmaa E; Metspalu A; Gardner P
    J Mol Diagn; 2005 Aug; 7(3):375-87. PubMed ID: 16049310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening practices for mutations in the CFTR gene ABCC7.
    Girodon-Boulandet E; Cazeneuve C; Goossens M
    Hum Mutat; 2000; 15(2):135-49. PubMed ID: 10649490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.